Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.

Palvella’s reverse merger with Pieris; AbbVie’s VC arm invests in anti-aging startup

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 25, 2024

MSD acquires Harpoon for $680m to strengthen T-cell engager armoury – Pharmaceutical Technology

Share this article Harpoon’s T-cell are engineered antibodies that redirect T cells to attack cancer cells. Image credit: Shutterstock/Meletios Verras. MSD has entered a definitive

January 9, 2024

Expanded methadone access: giving patients greater choice

WASHINGTON — Nicholas Voyles, executive director of the Indiana Recovery Alliance, ended up missing his daily dose of methadone on Monday. He’d requested “guest dosing”

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.